Search By Initial

Cas Index 2

• 239105-47-6 | (1R)-1-(4-methylphenyl)propan-1-amine,hydrochloride (Catalog# : 91106)Coming soon!
• 23844-66-8 | (1R)-2-methyl-1-phenylpropan-1-amine (Catalog# : 91103)Coming soon!
• 278788-60-6 | (2R)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid (Catalog# : 81724)Coming soon!
• 213261-59-7 | RITA (Catalog# : 52526)RITA(NSC 652287) induced both DNA-protein and DNA-DNA cross-links with no detectable
• 2911585-37-8 | SILA-123 (Catalog# : 26A014)SILA-123 is a type II FLT3 inhibitor that has shown highly potent inhibitory effects
• 2574524-67-5 | Soficitinib (Catalog# : 26A008)Soficitinibis a small-molecule inhibitor of non-receptor tyrosine-protein kinase (TYK
• 2260969-36-4 | Selnoflast (Synonyms: RO-7486967 ; IZD334) (Catalog# : 25167)Selnoflast , also known as RO-7486967 or IZD334, is a potent small molecule that inhi
• 2521285-05-0 | Sevabertinib ( BAY-2927088 ) (Catalog# : 25079)Sevabertinib ( BAY-2927088 ) is a oral, non-covalent, tyrosine kinase receptor inhibi
• 2805997-46-8 | Survodutide (Catalog# : 25043)
• 2097938-74-2 | Stafib-2 (Catalog# : 24142)Stafib-2 is a potent and selctive inhibitor of the transcription factor STAT5b, with
• 2589531-76-8 | Saruparib (Catalog# : 24100)Saruparib, also known as AZD5305 is a potent, selective and oral active PARP inhibito
• 2274723-90-7 | SPG-302 (Catalog# : 24065)Phenylbenzothiazole-PEG4-OH (compound 1) can treat spinal cord injury and promote spi
• 2226636-04-8 | Soquelitinib ( CPI-818 ) (Catalog# : 20671)Soquelitinib is an oral interleukin-2-inducible T cell kinase (ITK) inhibitor‌.
• 2222138-31-8 (HCl) | Sotuletinib HCl (Catalog# : 20663)Sotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor.
• 2383086-06-2 | Sonrotoclax (BGB-11417) (Catalog# : 20650)Sonrotoclax is an antineoplastic.
• 2546091-70-5 | SOP1812 (QN-302) (Catalog# : 20639)QN-302 is a G-quadruplex (G4)-selective transcription inhibitor.
• 256414-75-2 | SEW2871 (Catalog# : 20604)SEW2871 is a S1P1 agonist (sphingosine-1-phosphate type 1 receptor agonist). SEW2871
• 2765525-82-2 | STX-721 (Catalog# : 20576)STX-721 is a next-generation, orally delivered therapy, designed with potential best-
• 2648257-56-9 | STC-15 (Catalog# : 20549)STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me
• 2921961-53-5 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol (Catalog# : 20522)
• 2170746-98-0 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester (Catalog# : 20412)
• 2322245-42-9 (free base) | SRI-37330 free base (Catalog# : 1711224)SRI-37330 is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and
• 2370013-12-8 | Sunvozertinib ( DZD 9008 ) (Catalog# : 20369)Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective
• 2102681-49-0 | SHMT-IN-2 (Catalog# : 20368)SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting
• 2582757-90-0 | Stafia-1 (Catalog# : L20338)
• 2499663-01-1 | STM2457 (Catalog# : 20321)STM2457 is a highly potent and selective first-in-class catalytic inhibitor of METTL3
• 2322245-49-6 | SRI-37330 HCl (Catalog# : 20306)SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently
• 2089251-47-6 | SM-102 (Catalog# : 21252)SM-102 is an ionizable amino lipid that has been used in combination with other lipid
• 287383-59-9 | Scriptaid (Catalog# : 21229)Scriptaid, also known as GCK 1026, is a HDAC inhibitor. Scriptaid protects against tr
• 2351882-11-4 | Spastazoline (Catalog# : 2071521)Spastazoline is a novel inhibitor for aaa+ (atpases associated with diverse cellular